Relapsed Multiple Myeloma Pipeline Review, H2 2012 New Report
Relapsed Multiple Myeloma - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Relapsed Multiple Myeloma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Relapsed Multiple Myeloma.
View full press release